Brokerage CLSA said Nifty‘s absolute returns would be muted in 2025 as share valuations remain well above their long-term averages and their peers amid an uncertain and risky global environment. The firm said incoming US President Donald Trump’s policies on export-focused emerging markets like India and China, uncertainty around interest rate cuts, and a rising … Read more
Aimed at the trinity of fiscal prudence, investment, and growth momentum, the Union Budget saw the introduction of employment incentives and a simplified income tax regime, which should boost consumption. Investors were, however, caught off guard due to the increase in LTCG and STCG tax rates, leading to a knee-jerk reaction on D-Street. “While the … Read more
“You have got a good rainfall, inflation is under control and I think the choice and aspiration of growing to bigger banks is growing. I continue to think Hindustan Lever on any correction, so as Marico and Nestle, but our two outperformers there are going to be Bata and Patanjali,” says Sanjiv Bhasin, Director, IIFL … Read more
May 16, 2024, 07:08:12 PM IST Mutual funds buy and sell securities to actively manage their portfolios. Here is the list of top 10 largecap stocks sold by mutual funds in April, according to a report by ICICI Direct Research. ETMarkets.com 2/11 Jio Financial Services The fund houses had 2,661 lakh shares of Jio Financial … Read more
Nifty ended April derivative series higher by 1.1% in which market-wide rollovers were marginally higher as compared to the previous month and stood at 93.2% vs 92.9% last expiry. Thursday’s session saw Kotak Mahindra Bank shares ending 11% lower at Rs 1,643 on NSE while Hitachi Energy India shares ended nearly 14% up at Rs … Read more
Brokerage firm Jefferies maintained a buy on JB Pharma, Citigroup has a buy rating on Nestle India, CLSA recommended a sell on Nazara Technologies and Morgan Stanley maintained an Equal Weight rating on Trent. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Jefferies on JB Pharma: Buy| … Read more
Abhay Agarwal, Founder & Fund Manager, Piper Serica, says “outsourced manufacturing as a concept is here to stay and it will reward large players. While there is nothing wrong with branded players like Voltas or Blue Star, we would like to back very efficient, large and getting larger manufacturers like Dixon and Amber purely for … Read more
The pent-up demand fuelled by pandemic time savings is beginning to peter out for goods, but may last for some more time for services, say economists. Overall consumer demand is also expected to come under pressure from tighter monetary conditions and lesser pull from rural India. However, high-end consumption is expected to provide some support. … Read more
Shares of Nestle India surged as much as 4% in trade on Thursday and scaled a lifetime high, buoyed by the high dividend payout, stock split, and robust earnings for the September quarter. The Maggi noodles maker announced an interim dividend of Rs 140 a share, and the board also approved a 10-for-1 stock split. … Read more
After FMCG major Nestle India June quarter earnings beat Street’s expectations, US brokerage Jefferies recommended a ‘Hold’ on expensive valuations, while Nuvama and ICICI Securities recommended a ‘Buy’ and ‘Add’, respectively. Motilal Oswal has a ‘Neutral’ stance on the counter. The stock on Friday fell to the day’s low of Rs 22,187.30 on the NSE, … Read more